United Therapeutics shareholders elect Jan Malcolm to board, approve stock plan amendment adding 1.32M shares

UNITED THERAPEUTICS Corp

Jan Malcolm, former Minnesota Health Commissioner, elected to board; replaces Prof. Katherine Klein who did not stand for re-election.
Shareholders approved amendment to 2015 Stock Incentive Plan: adds 1,320,000 shares, extends expiration to April 25, 2034.
All 11 director nominees elected; advisory resolution on executive compensation passed with 94.8% of votes cast.
Ratification of Ernst & Young as independent auditor for 2024 approved by shareholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.